Glaukos Corp（GKOS）夜盘交易时段股价大涨6.33%，引发市场关注。
消息面上，公司于盘后发布了第二季度财报，业绩表现远超市场预期。数据显示，公司第二季度销售额达到1.856亿美元，较市场普遍预期的1.509亿美元高出约23%；调整后每股亏损0.14美元，优于预期的亏损0.22美元，亏损幅度同比也明显收窄。此外，公司还将全年销售指引上调至6.8亿至7.0亿美元，大幅超出FactSet此前6.3亿美元的一致预期。营收与指引双双亮眼，成为推动股价在夜盘持续走强的核心催化剂。
此前，公司已宣布Preserflo™微型引流器510(k)关键性研究完成全部患者入组，标志着该产品美国上市进程迈出关键一步，管线进展也对市场情绪形成正向支撑。机构方面，Truist、Needham等多家机构维持买入评级并上调目标价，整体市场情绪偏多。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.